期刊文献+

HPV16 E7 siRNA表达载体对宫颈癌CaSki细胞生物学活性的影响 被引量:3

Effect of HPV16 E7 specific-siRNA expression on biological activity of cervical cancer CaSki cells
下载PDF
导出
摘要 目的探讨人乳头瘤病毒16型(HPV16)E7基因小干扰RNA(siRNA)表达载体对宫颈癌CaSki细胞生物学活性的影响。方法利用脂质体HPV16 E7特异性siRNA表达载体(HPV16-E7Si)、空载体(CaSki-Si)转染CaSki细胞,荧光定量RT-PCR、流式细胞仪检测HPV16-E7Si、CaSki-Si细胞E7 mRNA和蛋白的变化;流式细胞仪及MTT法检测2种细胞的细胞周期及生长曲线变化,并检测2种细胞对顺铂的敏感性。结果成功获得沉默E7基因的克隆细胞株CaSki-E7Si及阴性对照CaSki-Si;CaSki-E7Si细胞生长明显慢于CaSki-Si细胞(P<0.05),且前者细胞的凋亡峰明显增多。2种细胞加用顺铂作用48 h后发现,CaSki-Si细胞周期阻滞在S~G2期,HPV16-E7Si阻滞在G0~1期。结论 HPV16 E7 siRNA表达载体能有效地抑制宫颈癌CaSki细胞E7基因的表达,促进肿瘤细胞凋亡,并增加顺铂的敏感性。 Objective To investigate a new potential therapy to achieve targeted inhibition of HPV16 E7 oncogene in tumor cells using small interfering RNAs (siRNA). Methods The HPV16 E7 siRNA and scramble control expression plasmids were structured and transfected into CaSki cells by liposome. The stable cell lines of HPV16 E7 siRNA were es tabhshed by Hygromycin screening. The expression levels of HPV16 E7 mRNA and protein were detected by RT-PCR, im munofluorescence and flowcytometry. The cell cycle and cell proliferation were measured with flowcytometry and MTY meth od. Meanwhile the cisplatin chemotherapy sensitivity was observed in the cells. Results Plasmids HPV16 E7 siRNA and scramble control were constructed and confirmed by sequencing. HPV16 E7 mR_NA and protein expressions were signifi cantly decreased in the HPV16-E7Si cells compared with the CaSki-Si control cells. The cell growth rate of HPV16-E7Si cells was significantly inhibited. Flowcytometry analysis revealed a significant increase in apoptosis. In addition, after cis platin(DDP) treatment for 48 hours the ratio of G0-l phase of HPV16-ETSi cells was increased compared with control cells. Conclusion HPV16 E7 siRNA could successfully suppress CaSki cell growth and induce the cell apoptosis, and increases sensitivity of the cisplatin chemotherapy.
出处 《山东医药》 CAS 2012年第29期10-13,共4页 Shandong Medical Journal
基金 湖北省教育厅自然科学研究重点项目(D20121308)
关键词 宫颈肿瘤 乳头状瘤病毒 SIRNA表达载体 顺铂 cervix neoplasms papillomavirus, human siRNA expression vector cisplatin
  • 相关文献

参考文献10

  • 1Narisawa-Saito M, Kiyono T. Mechanisms of high-risk human papil- lomavirus-induced cervical carcinogenesis [ J ]. Nihon Rinsho, 2009,67 ( 1 ) :53-61.
  • 2Lee SK, Kumar P. Conditional RNAi : towards a silent gene therapy [J]. Adv Drug Deliv Rev, 2009,61 (7-8) :650-664.
  • 3Sima N, Wang S, Wang W, et al. Antisense targeting human papil- lomavirus type 16 E6 and E7 genes contributes to apoptosis and se- nescence in SiHa cervical carcinoma cells [ J ]. Gyneeol Oneol, 2007,106 ( 2 ) : 299-304.
  • 4江雨,李清,李健,周裕林.闽南女性人乳头状瘤病毒感染流行病学调查分析[J].现代预防医学,2010,37(1):110-111. 被引量:21
  • 5Wu TC. Therapeutic human papillomavirus DNA vaccination strate- gies to control cervical cancer[ J]. Eur J Immunol, 2007,37 (2) : 310-314.
  • 6徐波,胡丽娜,顾美礼.人乳头状瘤病毒E6、E7原癌蛋白致癌的机制[J].国外医学(妇产科学分册),2001,28(4):198-200. 被引量:18
  • 7杨永林.RNAi的作用机制与抗病毒效应的研究进展[J].国外医学(病毒学分册),2003,10(5):135-138. 被引量:3
  • 8牛晓宇,彭芝兰,王和.RNA干涉抑制宫颈癌CaSki细胞株HPV16 E6基因的研究[J].癌症,2004,23(11):1257-1262. 被引量:27
  • 9Ledwaba T, Dlamini Z, Naicker S, et al. Molecular genetics of hu- man cervical cancer: role of papillomavirus and the apoptotic cas- cade[J]. Biol Chem, 2004,385(8) :671-682.
  • 10Muggia FM. Recent updates in the clinical use of platinum com- pounds for the treatment of gynecologic cancers [ J ]. Semin Oncol, 2004,31 (6 Suppl 14) :17-24.

二级参考文献70

  • 1蔡虹.深圳市城区育龄妇女HPV感染状况调查[J].中国妇幼保健,2004,19(9):90-92. 被引量:46
  • 2杨英捷,赵健,李雪倩,廖秦平.人乳头状瘤病毒不同亚型感染与宫颈病变的相关性[J].中国妇产科临床杂志,2006,7(4):253-256. 被引量:54
  • 3Munoz N, Bosch FX, Sanjose S, et al. Epidemiologic clas-sification of human papillomavirus types associated withcervical cancer [J].N Engl J Med, 2003, 348 (6): 518-527.
  • 4Walboomers JM, JacobsMV, ManosMM, et al. Human papillomavirus is a necessary cause of invasive cervical cancerworldwide [J].J Patho, 1999, 189: 12-19.
  • 5Ding DC, H.C, Hsu, et al. Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: An indication of viral oncogenic potential [J ]. Eur J Obstet Gynecol Reprod Biol, 2008, 140 (2): 245-51.
  • 6Clifford GM, Smith JS, PlummerM, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis[J]. Br J Cancer, 2003, 88: 63-73.
  • 7Lo KW, Wong YF, Chan MK, et al. Prevalence of human papillomavirus in cervical cancer: amulticenter study in China [J]. Int J Cancer, 2002, 100: 327-331.
  • 8Huang S, Afonina I, Miller BA, et al. Huamn papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinesewomen[J]. Int J Cancer, 1997, 73: 775-776.
  • 9Guo S,Kemphues KJ.Cell,1995;81(4):611~620.
  • 10Fire A,Xu S,Montgomery MK,et al.Nature,1998;391:806~811.

共引文献64

同被引文献31

  • 1SJ Moghaddam,EN Haghighi,S Samiee,N Shahid,AR Keramati,S Dadgar,MR Zali.Immunohistochemical analysis of p53,cyclinD1,RB1,c-fos and N-ras gene expression in hepatocellular carcinoma in Iran[J].World Journal of Gastroenterology,2007,13(4):588-593. 被引量:73
  • 2乐杰.妇产科学[M].第7版.北京:人民卫生出版社,2011:278-84.
  • 3Do C L, Mankame T P, Langerman A, et al. Char acterization of NOL7 gene point mutations, promoter melhyla- tion, and protein expression in cervical eancer[J]. International iournal of gynecological pathology: official journal of the Inter nalional Society of Gynecological Pathologists, VOLE.2012,31 ( 1 ) : 15.
  • 4Moody G A, I.aimins I. A. Human papillomaviros oncoproteins: pathways 1o transformation[J]. Nalure Reviews Cancer, 2010, 10(8): 550- 560.
  • 5la Cruz-Herndndez D, Perez Plasencia C, Perez Cardenas E, et al. Transcriptional changes induced by epige netic therapy with hydralazine and magnesium valproate in cer vicalcarcinoma[J]. Oncology reports, 2011, 25(2): 399-407.
  • 6Castellsague X, Drudis T, Canadas MP, et al. Human Papilloma- virus (HPV) infection in pregnant women and mother - to - child transmission of genital HPV genotypes: a prospective study in Spain[J]. BMC Infect Dis, 2009, 9(10) : 1471 -1474.
  • 7Wang SS, Bratti MC, Rodriguez AC, et al. Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical caner [ J]. J Infect Dis, 2009, 199(1) : 20 -30.
  • 8Yoon JH, Yoo SC, Kim WY, et al. Role of HPV DNA testing for detection of high - grade cervical lesions in women with atypical squamous cells of undetermined significance: a prospective study in a Korean population[ J]. Eur J Gynaecol Oncol, 2009, 30(3) :271 -274.
  • 9石玲玲,唐娜,崔艳艳,贡雪,李建华.Pin1,CyclinD1在宫颈癌中的表达及与HPV16/18感染的关系[J].微生物学杂志,2008,28(3):21-25. 被引量:4
  • 10任晓辉,王珏,姚智敏,马学谦,裴毅.p16、cyclin D1在消化道癌细胞周期调控中的关系探讨[J].现代生物医学进展,2009,9(15):2968-2970. 被引量:8

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部